Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-441P, or "RNA, U6 small nuclear 441, pseudogene," is a pseudogene corresponding to the U6 small nuclear RNA (snRNA) family. U6 snRNA is an essential component of the spliceosome, which is involved in the removal of introns from pre-mRNA via splicing in eukaryotic nuclei. However, RNU6-441P itself is a nonfunctional, non-coding RNA gene copy—classified as a pseudogene—generated through retrotransposition or other duplication mechanisms and does not code for a functional RNA molecule. It does not have a known biological function, disease association, therapeutic targeting relevance, or established use as a biomarker. Multiple copies of U6 snRNA pseudogenes are present in the human genome and serve, at best, as markers of retrotransposition activity in genomic studies. Summary of correctness: RNU6-441P is not a therapeutic target, but a processed non-functional pseudogene. Listing it as a druggable or disease-relevant target would be incorrect. The entry is a valid locus but not a functional or receptor target of pharmacological interest.
None (not a functional gene or protein)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 441, pseudogene (RNU6-441P).